Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

First Financial Bancorp Director Makes a Buy

First Financial Bancorp DirectorRichard E. Olszewski, Director at First Financial Bancorp (NASDAQ:FFBC), reported on October 15, 2013, the purchase of 442 shares of common stock, at a price of $15.04 each, for a total transaction worth $6,647 approximately. Under the company’s Directors Fee Stock Plan, Mr. Olszewski now controls 9,494 shares, in addition to the 8,135 shares of common stock under direct control. The latest acquisition has placed a total of 17,629 shares of common stock under his direct control.

First Financial Bancorp (NASDAQ:FFBC)

Mr. Olszewski also indirectly controls another 16,233 shares of common stock: 8,291 shares are held in a joint brokerage account, another 1,400 shares are placed in an individual retirement account, while 4,922 shares are jointly controlled with the spouse, and 1,620 shares are through an undisclosed entity. Hence, Mr. Olszewski control, directly and indirectly, a total of 33,862 shares for an estimated capital investment of $519,781. Lastly, Mr. Olszewski has a stock option for 8,663 shares of common stock, set to expire on June 28, 2015.

The stock price of First Financial has been irregular throughout the last 12 months, reaching a high of $16.47 on October 17, 2012, and climbing to the same mark on August 8, 2013.

Currently, the stock is trading at 14.5 times its trailing earnings, about a point above the industry average. It pays $0.15 in the form of quarterly dividends, representing a 3.9% annual yield. Special dividends have been paid three times this year, once every three months for values of $0.13, $0.09, and $0.12. A new special dividend payment is expected for the upcoming month.

Disclosure: Jodor Jalit holds no position in any of the mentioned stocks.

Recommended Reading:

Repros Therapeutics: New Drug Development Stimulates Insider Trading

Yum! Brands’ Board of Directors is Eating Up Stock

A Six-Pack of Stocks With Promising Insider Trading Activity

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!